150 related articles for article (PubMed ID: 26143155)
1. Disabled homolog 2 is required for migration and invasion of prostate cancer cells.
Xie Y; Zhang Y; Jiang L; Zhang M; Chen Z; Liu D; Huang Q
Front Med; 2015 Sep; 9(3):312-21. PubMed ID: 26143155
[TBL] [Abstract][Full Text] [Related]
2. [Effects of miR-145 on the migration and invasion of prostate cancer PC3 cells by targeting DAB2].
Xie S; Xie Y; Zhang Y; Huang Q
Yi Chuan; 2014 Jan; 36(1):50-7. PubMed ID: 24846918
[TBL] [Abstract][Full Text] [Related]
3. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.
Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY
Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885
[TBL] [Abstract][Full Text] [Related]
4. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.
Nakane K; Fujita Y; Terazawa R; Atsumi Y; Kato T; Nozawa Y; Deguchi T; Ito M
Int J Urol; 2012 Jan; 19(1):71-9. PubMed ID: 22050448
[TBL] [Abstract][Full Text] [Related]
8. Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma.
Wang WL; Chang WL; Yang HB; Wang YC; Chang IW; Lee CT; Chang CY; Lin JT; Sheu BS
Oncotarget; 2016 Nov; 7(44):71169-71181. PubMed ID: 27036032
[TBL] [Abstract][Full Text] [Related]
9. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
11. The expression of disabled-2 is common reduced in meningiomas.
Zhang Z; Chen Y; Xie X; Tang J
Neurol India; 2014; 62(1):57-61. PubMed ID: 24608456
[TBL] [Abstract][Full Text] [Related]
12. Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.
Ge C; Zhao G; Li Y; Li H; Zhao X; Pannone G; Bufo P; Santoro A; Sanguedolce F; Tortorella S; Mattoni M; Papagerakis S; Keller ET; Franceschi RT
Oncogene; 2016 Jan; 35(3):366-76. PubMed ID: 25867060
[TBL] [Abstract][Full Text] [Related]
13. Effects of zinc finger protein 403 on the proliferation, migration and invasion abilities of prostate cancer cells.
Xu X; Zhu Z; Xu Y; Tian S; Jiang Y; Zhao H
Oncol Rep; 2020 Dec; 44(6):2455-2464. PubMed ID: 33125130
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
[TBL] [Abstract][Full Text] [Related]
15. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.
Zhu C; Li J; Ding Q; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Qin C; Hua L; Shao P; Yin C
Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133
[TBL] [Abstract][Full Text] [Related]
16. GRP78 Participates in PCA3-regulated Prostate Cancer Progression.
Lin C; Wang J; Wang Y; Zhu P; Liu X; Li N; Liu J; Yu L; Wang W
Anticancer Res; 2017 Aug; 37(8):4303-4310. PubMed ID: 28739722
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
18. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
